⌘K

Login Start Free

Home/Filings/4/0001209191-22-023749

4//SEC Filing

OELKE MATHIAS 4

Accession 0001209191-22-023749

CIK 0001538210other

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 7:24 PM ET

Size

8.6 KB

Accession

0001209191-22-023749

Insider Transaction Report

Form 4

Period: 2022-04-05

NexImmune, Inc.NEXI

Chief Science Officer

Transactions

Award
Stock Option (Right to Buy)
2022-04-05+60,000→ 60,000 total
Exercise: $4.22Exp: 2032-04-04→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Oelke's continued service to the corporation on each vesting date.

Documents

2 files

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1

filerCIK 0001921607

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 7:24 PM ET
Size: 8.6 KB

View on SEC.gov